WuXi Biologics and Bayer Enter into an Acquisition Agreement on a Drug Product Plant in Germany
SHANGHAI and LEVERKUSEN – WuXi Biologics (“WuXi Bio”) (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, and Bayer jointly announced an acquisition agreement that WuXi Biologics Germany GmbH will take over the operations of one of Bayer’s final drug product manufacturing plants in Leverkusen, Germany, and purchase the associated equipment, in combination with a long-term lease contract for the building.
Based on a manufacturing agreement to be negotiated, the plant would be operated by WuXi Biologics and serve as a back-up site for the final product manufacturing of Kovaltry™, an antihemophilic factor (recombinant). The transaction is expected to be concluded in the coming months subject to the satisfaction of customary closing conditions. Financial details were not disclosed.
“We are excited to sign this acquisition agreement with Bayer, allowing us to have quick access to high quality drug product manufacturing capacities and capabilities,” said Dr. Chris Chen, CEO of WuXi Biologics. “Our business in EU, US and China market has experienced robust growth in the past few years. This additional drug product plant further confirms our commitment to ‘Global Dual Sourcing within WuXi Biologics’ strategy. WuXi Biologics will continue to expand our worldwide capacity, providing global partners with a robust and premier-quality supply chain network to benefit patients worldwide.”
Latest news
UPM receives triple sustainability certification for the Leuna biorefinery
Leuna Chemical Complex →The Leuna biorefinery is the world’s first industrial-scale facility of its kind, converting wood into advanced biochemicals at scale. This milestone reinforces UPM’s role as a frontrunner in susta...
On stream: BASF starts up new world-scale plant for hexamethylenediamine in Chalampé, France
Increase of BASF’s HMD production capacity to 260,000 metric tons Expansion of polyamide business together with polyamide 6.6 production in Freiburg
BASF starts commercial operation of Black Mass plant for Battery Recycling in Schwarzheide, Germany
It is one of the biggest commercial Black Mass plants in Europe, with an annual processing capacity of up to 15,000 tons of end-of-life lithium-ion batteries and production scrap. This equals rough...
Clariant's ShiftMax™ 100 RE catalyst powers INERATEC´s groundbreaking e-Fuels plant at Frankfurt Höchst
Industriepark Höchst →Clariant supplies its innovative ShiftMax 100 RE catalyst for INERATEC's first commercial-scale e-Fuels plant in Industry Park Hoechst, Germany. The catalyst enables efficient conversion of green h...